Drug Trial Radar · NCT02352896
Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
Last checked: Nov 20, 2026Latest source record: Oct 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jan 31, 2014
Primary completion
Oct 30, 2023
Study completion Oct 30, 2023
Sponsor
- Lead sponsor
- PTC TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 2, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
EPI-743 in Leigh syndrome participants that participated in previous EPI743-12-002 (NCT01721733) study.
Conditions
- Leigh Syndrome
Interventions
EPI-743Drug
EPI-743 100 milligrams/milliliter (mg/mL) oral solution will be administered per dose and schedule specified in the arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease Severity as Measured by Newcastle Pediatric Mitochondrial Disease Scale (NPMDS) Sections 1-3 ScoreTime frame: Baseline up to Month 36
- Number of Participants With Dose-Limiting Serious Adverse Events (SAEs)Time frame: Baseline up to Month 36
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Gregory Enns
Stanford University, California
Akron Children's Hospital
Akron, Ohio
Baylor College of Medicine
Houston, Texas
Seattle Children's Hospital
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.